Moreover, morroniside reduced NPC pyroptosis by activating the Nrf2/Keap1 pathway, further supporting its therapeutic potential in IDD (Ge et al., 2024). This evidence concerns the gene NFE2L2 and intervertebral disk degenerative disorder.